EDIT

Editas Medicine Inc.

Price

$3.25

return (12m)

23.57%

p/e

-4.50

p/bv

3.16

DIVIDEND YIELD

0.00%

EDIT price

Editas Medicine

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EDIT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.65%

3 months

21.27%

1 year

23.57%

2 years

-20.73%

5 years

-94.62%

10 years

-83.26%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals EDIT

Valuation

P/E

-4.50

Sector -4.38

Industry -4.38

P/BV

3.16

Sector 2.02

Industry 2.02

P/Revenue (PSR)

7.08

Sector -4.40

Industry -4.40

EV/EBITDA

-7.22

Sector -263.09

Industry -263.09

EV/EBIT

-7.04

Sector -702.90

Industry -702.90

P/EBITDA

-4.93

Sector -4.39

Industry -4.39

P/EBIT

-4.76

Sector -4.73

Industry -4.73

P/Total Assets

1.40

Sector 1.49

Industry 1.49

P/Net Current Assets

3.87

Sector -11.70

Industry -11.70

P/Working Capital

2.22

Sector -3.19

Industry -3.19

EPS

-0.62

Sector -2.14

Industry -2.14

BVPS

0.88

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-140.87%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-144.41%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.05

Sector 0.03

Industry 0.03

Profitability

ROE

-70.24%

Sector -65.14%

Industry -65.14%

ROA

-31.16%

Sector -65.53%

Industry -65.53%

ROIC

-147.74%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.19

Sector 2.90

Industry 2.90

Net Debt / EBITDA

12.64

Sector -6.07

Industry -6.07

Net Debt / EBIT

12.33

Sector -8.26

Industry -8.26

Net Debt / Equity

-2.01

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.44

Sector 0.41

Industry 0.41

Liabilities/Assets

0.56

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

12.96%

Sector -

Industry -

5Y Earnings CAGR

-17.42%

Sector -

Industry -

Fundamentals EDIT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
EDIT Editas Medicine Inc.	$3.25	19.05%	0.00%	-4.50	3.16	-70.24%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EDIT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Editas Medicine

Editas Medicine Inc.

Average Investor10 user rating

4.0 (2 people)

United States

13 years

Founded: 2013

2016

Time since IPO - 10 years

235

Employees

Editas Medicine Inc. (United States) is listed on the Nasdaq and has a market capitalization of $332.61 million, with shareholders equity totaling $105.28 million.

The company employs approximately 235 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Editas Medicine Inc. reported $47.00 million in revenue, generating net income of $-73.95 million.

Key financial metrics include a P/E ratio of -4.50, a price-to-book (P/B) ratio of 3.16, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EDIT.

Market cap

$332.61 million

Net worth

$105.28 million

$105,280,000.00

Assets

$237.36 million

$237,360,000.00

Total Shares Outstanding

119.00 million

119,000,000

Average Daily Trading Volume

$2.17 million

$2,173,346.00

Sector

Health Care

Industry

Biotechnology

EDIT

EDIT revenue and profits

Financial Results EDIT

DRAG THE FRAME TO SEE MORE DATA

EDIT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Editas Medicine (EDIT) today?

A cotação de Editas Medicine (EDIT) hoje está em US$ 3.25, com uma variação de 23.57% em relação ao último ano. A cotação de Editas Medicine (EDIT) iniciou o ano negociando na casa dos US$ 2.05 e hoje está em US$ 3.25. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Editas Medicine (EDIT) e dados de ações do Ibovespa e mercados internacionais.

Quando Editas Medicine (EDIT) paga dividendos?

Editas Medicine (EDIT) não distribuiu dividendos no último ano.

Is Editas Medicine (EDIT) a good investment?

Atualmente, Editas Medicine (EDIT) está cotada a US$ 3.25, com um P/L de -4.50, representando um desvio de -287% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 23.57 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 23.57%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Editas Medicine (EDIT) stock?

Investir em ações de Editas Medicine (EDIT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Editas Medicine (EDIT) yield today?

A rentabilidade de Editas Medicine (EDIT) foi de 12.65% no último mês, 23.57% no último ano e -94.62% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Editas Medicine (EDIT) hoje, o investimento total seria de US$ 325.00, com base na cotação atual de US$ 3.25.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 401.60
Em 5 anos: US$ 17.49
Em 10 anos: US$ 54.41

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

EDIT

Editas Medicine Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment EDIT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING EDIT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Editas Medicine

Editas Medicine Inc.

United States

13 years

2016

235

PROFIT X PRICE EDIT

Financial Results EDIT

EDIT cash flow

Asset, Revenue and Profit Growth - EDIT

EDIT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions